Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2026)

Elanco Animal Health has disclosed Share-based Compensation across 10 years of filings, most recently posting $21.0 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $21.0 million, up 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.0 million (up 25.42% YoY), and the FY2025 annual result was $68.0 million, up 23.64% from the prior year.
• Share-based Compensation came in at $21.0 million for Q1 2026 at Elanco Animal Health, up from $16.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $21.0 million in Q1 2026 to a low of $9.0 million in Q2 2023.
• The 5-year median for Share-based Compensation is $15.0 million (2022), against an average of $14.6 million.
• Across the five-year window, Share-based Compensation sank 47.06% in 2023 and surged 55.56% in 2024, its largest moves.
• Elanco Animal Health's Share-based Compensation stood at $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then rose by 6.67% to $16.0 million in 2025, then surged by 31.25% to $21.0 million in 2026.
• The last three Share-based Compensation figures came in at $21.0 million (Q1 2026), $16.0 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.